Kimberly‑Clark Lowers Full‑Year Sales and Profit Guidance Amid China Diaper Quality Claims

Kimberly‑Clark Corporation (NYSE: KMB) this week confirmed that it has cut its full‑year 2026 sales and profit forecasts following a decline in second‑quarter performance, attributing the softness to false social‑media claims about Huggies diapers in China hurting sales.

The announcement coincided with the company’s Q2 results released on August 4, 2026. The firm said that unfounded quality allegations circulating on Chinese social platforms significantly disrupted demand for its baby care products, prompting the revision in outlook. The updated guidance reflects expectations for both sales and profit to underperform earlier projections for the year.

This development marks a material setback for Kimberly‑Clark’s top‑line momentum and highlights the impact of reputational issues in key markets. China represents a significant and growing segment of the company’s international business. Though the denial was supported by independent third‑party testing from a government‑certified lab, the reputational impact has persisted.

Investors should monitor whether the company implements further mitigation measures, such as enhanced quality communication or promotional efforts, to restore confidence among Chinese consumers. Any recovery in demand will be critical to recouping lost ground in the region and validating the updated guidance.

Separately, Kimberly‑Clark has been advancing its innovation strategy, including launching a plant‑based fiber program under its “Better Care for a Better World” initiative earlier in August. While unrelated to the China disruption, such efforts may bolster longer‑term resilience by strengthening brand differentiation and sustainability credentials.

At the same time, institutional interest remains robust. Freedom Capital lifted its rating on the stock to “strong‑buy,” even as the broader consensus remains more cautious. Analysts at UBS raised their price target following productivity gains in the quarter, though TD Cowen maintained a hold rating amid ongoing operational concerns.

With the stock trading at approximately 109.55—reflecting a 1.26% intraday decline as of August 28, 2026—market participants are studying whether the revised outlook and reputational headwinds will materially impact Kimberly‑Clark’s market valuation in the near term.